Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in EBS — Emergent BioSolutions Inc.

CIK 1446194 BALA CYNWYD, PA
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$146,985
-$255,058 QoQ
Shares Held
17,540
-63.8% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Derivatives in EBS

reported options exposure · as of Jun 30, 2026
CallValue
$2,420,144
CallShares
288,800
PutValue
$785,206
PutShares
93,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. EBS ranks #40 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in EBS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,985 17,540
2026-06-30 $2,420,144 288,800
2026-06-30 $785,206 93,700
2026-03-31 $402,043 48,439
2026-03-31 $1,322,190 159,300
2026-03-31 $435,750 52,500
2025-12-31 $467,208 37,800
2025-12-31 $4,668,520 377,712
2025-12-31 $1,832,988 148,300
2025-09-30 $2,460,365 278,953
2025-09-30 $1,365,336 154,800
2025-09-30 $661,500 75,000
2025-06-30 $320,914 50,300
2025-06-30 $1,555,424 243,797
2025-06-30 $236,698 37,100
2025-03-31 $174,474 35,900
2025-03-31 $4,127,952 849,373
2025-03-31 $269,730 55,500
2024-12-31 $1,613,728 168,800
2024-12-31 $8,802,685 920,783
2024-12-31 $612,796 64,100
2024-09-30 $1,768,530 211,800
2024-09-30 $2,018,195 241,700
2024-09-30 $3,712,952 444,665
2024-06-30 $1,531,110 224,503
2024-06-30 $855,910 125,500
2024-06-30 $448,074 65,700
2024-03-31 $63,250 25,000
2024-03-31 $32,384 12,800
2023-12-31 $132,141 55,059
2023-09-30 $1,203,820 354,065
2023-06-30 $2,116,894 288,013
2023-06-30 $192,570 26,200
2023-03-31 $155,400 15,000
2023-03-31 $5,749,157 554,938
2022-12-31 $536,386 45,418
2022-12-31 $336,585 28,500
2022-12-31 $164,159 13,900
2022-09-30 $2,041,676 97,269
2022-06-30 $263,840 8,500
2022-06-30 $1,871,712 60,300
2022-06-30 $881,876 28,411
2022-03-31 $1,954,456 47,600
2022-03-31 $468,084 11,400
2022-03-31 $1,830,495 44,581
2021-12-31 $917,217 21,100
2021-12-31 $2,269,134 52,200
2021-12-31 $4,169,554 95,918
2021-09-30 $1,206,687 24,100
2021-09-30 $2,808,025 56,082